M
Mixlab
A next-gen veterinary compounding pharmacy
At a glance
- Founded
- 2017
- Headquarters
- New York City, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
- BVBrand Foundry Ventures
- LVLakehouse Ventures
- XVXFactor Ventures
- MPMonogram Capital Partners
- MPMars Petcare
Global Founders Capital
Series A3 investors entered at this stage
- SBSonoma Brands
- LSLeap Venture Studio
- VCVanterra Capital
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Investments and acquisitions
Disclosed deals where Mixlab was the backer or acquirer, 2024–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Mixlab's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Mixlab's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mixlab on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mixlab on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.